2021
Working Paper
HBS Working Paper Series

Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent

By: Rembrand Koning, Sampsa Samila and John-Paul Ferguson

Format:Print
| Language:English
| Pages:45

Abstract

Has the increase in female medical researchers led to more medical advances for women? In this paper, we investigate if the gender of inventors shapes their types of inventions. Using data on the universe of U.S. biomedical patents, we find that patents with women inventors are significantly more likely to focus on female diseases and conditions. Consistent with the idea of women researchers choosing to innovate for women, we find stronger effects when the lead inventor on the patent is a woman. Women-led research teams are 26% more likely to focus on female health outcomes. This link between the gender focus of the scientist and the type of invention, in combination with the rise of women inventors, appears to have influenced the direction of innovation over the last four decades. Our findings suggest that the demography of inventors matters not just for who invents but also for what is invented.

Keywords

Innovation; Biomedical Research; Innovation and Invention; Diversity; Gender; Research; Health; United States

Citation

Koning, Rembrand, Sampsa Samila, and John-Paul Ferguson. "Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent." Working Paper. (Harvard Business School Working Paper, No. 19-124, June 2019; SSRN Working Paper Series, No. 3401889, June 2019.)